CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,786,223 | +261.7% | 656,353 | +165.7% | 0.00% | – |
| Q2 2023 | $2,705,373 | -77.8% | 247,066 | -82.3% | 0.00% | -100.0% |
| Q1 2023 | $12,195,993 | +276.5% | 1,398,623 | +170.7% | 0.00% | +100.0% |
| Q4 2022 | $3,239,508 | +389.4% | 516,668 | +173.1% | 0.00% | – |
| Q3 2022 | $662,000 | +120.7% | 189,184 | +85.8% | 0.00% | – |
| Q2 2022 | $300,000 | -53.2% | 101,800 | -50.6% | 0.00% | – |
| Q1 2022 | $641,000 | -62.3% | 206,018 | -59.0% | 0.00% | – |
| Q4 2021 | $1,700,000 | +27.7% | 502,690 | +37.9% | 0.00% | – |
| Q3 2021 | $1,331,000 | -41.3% | 364,600 | -29.9% | 0.00% | – |
| Q2 2021 | $2,268,000 | +4.8% | 520,233 | +9.1% | 0.00% | – |
| Q1 2021 | $2,165,000 | -61.8% | 477,029 | -51.7% | 0.00% | – |
| Q4 2020 | $5,664,000 | +77.6% | 987,046 | +124.0% | 0.00% | – |
| Q3 2020 | $3,190,000 | +21.4% | 440,600 | -41.5% | 0.00% | – |
| Q2 2020 | $2,627,000 | +1905.3% | 752,577 | +748.3% | 0.00% | – |
| Q1 2020 | $131,000 | -49.4% | 88,715 | -32.9% | 0.00% | – |
| Q4 2019 | $259,000 | -91.4% | 132,195 | -77.5% | 0.00% | -100.0% |
| Q3 2019 | $3,011,000 | -71.9% | 588,077 | -60.7% | 0.00% | 0.0% |
| Q2 2019 | $10,706,000 | +583.2% | 1,495,184 | +1167.1% | 0.00% | – |
| Q1 2019 | $1,567,000 | +280.3% | 118,000 | +125.6% | 0.00% | – |
| Q4 2018 | $412,000 | -47.8% | 52,300 | -26.5% | 0.00% | – |
| Q3 2018 | $789,000 | -24.4% | 71,200 | -8.5% | 0.00% | – |
| Q2 2018 | $1,044,000 | -63.3% | 77,800 | -64.5% | 0.00% | -100.0% |
| Q1 2018 | $2,848,000 | +361.6% | 219,167 | +227.1% | 0.00% | – |
| Q4 2017 | $617,000 | +8.8% | 67,000 | -4.8% | 0.00% | – |
| Q3 2017 | $567,000 | +636.4% | 70,390 | +427.3% | 0.00% | – |
| Q2 2017 | $77,000 | +79.1% | 13,349 | -47.5% | 0.00% | – |
| Q4 2015 | $43,000 | -88.5% | 25,405 | -53.0% | 0.00% | – |
| Q1 2015 | $374,000 | – | 54,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |